
Emory research connected to second patient in sustained remission of HIV
Emory researcher Christina Gavegnano’s pioneering work with a class of small molecules known as JAK inhibitors continues to generate interest into how HIV might be cured after a second patient who received the treatment was declared to be in long-term remission.
Full Story